Spectral AI (NASDAQ:MDAI) & Revolutions Medical (OTCMKTS:RMCP) Financial Survey

Revolutions Medical (OTCMKTS:RMCP) and Spectral AI (NASDAQ:MDAI) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their institutional ownership, profitability, analyst recommendations, risk, dividends, earnings and valuation.

Volatility and Risk

Revolutions Medical has a beta of -0.43, indicating that its stock price is 143% less volatile than the S&P 500. Comparatively, Spectral AI has a beta of 0.47, indicating that its stock price is 53% less volatile than the S&P 500.

Insider & Institutional Ownership

67.1% of Spectral AI shares are held by institutional investors. 10.5% of Revolutions Medical shares are held by company insiders. Comparatively, 56.7% of Spectral AI shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Valuation and Earnings

This table compares Revolutions Medical and Spectral AI”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Revolutions Medical	N/A	N/A	N/A	N/A	N/A
Spectral AI	$18.06 million	1.87	-$20.85 million	($0.65)	-2.80

Revolutions Medical has higher earnings, but lower revenue than Spectral AI.

Profitability

This table compares Revolutions Medical and Spectral AI’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Revolutions Medical	N/A	N/A	N/A
Spectral AI	-40.78%	N/A	-77.87%

Analyst Ratings

This is a summary of current ratings and target prices for Revolutions Medical and Spectral AI, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Revolutions Medical	0	0	0	0	0.00
Spectral AI	0	0	2	1	3.33

Spectral AI has a consensus price target of $4.75, indicating a potential upside of 161.28%. Given Spectral AI’s stronger consensus rating and higher probable upside, analysts clearly believe Spectral AI is more favorable than Revolutions Medical.

Summary

Spectral AI beats Revolutions Medical on 8 of the 10 factors compared between the two stocks.

About Revolutions Medical

Revolutions Medical Corporation, a development stage company, is engaged in the design, development, and commercialization of auto retractable vacuum safety syringes in the United States and internationally. The company develops RevVac auto retractable vacuum safety syringe, which is designed to reduce accidental needle stick injuries and lower the spread of blood borne diseases. It is also developing a suite of magnetic resonance imaging software tools consisting of RevColor, Rev3D, RevDisplay, and RevScan that are designed to enhance general diagnostic confidence through education and research use. The company sells its products to acute care hospitals, alternate care facilities, doctors' offices, clinics, emergency centers, surgical centers, convalescent hospitals, veterans administration facilities, military organizations, public health facilities, and prisons through distributors. Revolutions Medical Corporation was founded in 1996 and is headquartered in Charleston, South Carolina.

About Spectral AI

Spectral AI, Inc., an artificial intelligence (AI) company, focuses on developing predictive medical diagnostics in the United States. The company develops medical diagnostics for faster and accurate treatment decisions in wound care with applications involving patients with burns and diabetic foot ulcers. Its products include DeepView System, a predictive analytics platform integrated with the predictive AI-Burn, which combines AI algorithms and multispectral imaging (MSI) imaging for an assessment of wound healing potential and offers clinicians an objective and immediate assessment of a wound’s healing potential prior to treatment or other medical intervention; and DeepView SnapShot M, a handheld, portable, and wireless diagnostic tool, that provides a potential enhanced and expanded use for the government and emergency care, first responders, and potentially home health care professionals. The company is headquartered in Dallas, Texas.